We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.09B
AUM Growth
+$15.8M
Cap. Flow
-$86M
Cap. Flow %
-4.12%
Top 10 Hldgs %
18.08%
Holding
266
New
20
Increased
45
Reduced
134
Closed
56

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18.8M
2
TENB icon
Tenable Holdings
TENB
+$16.8M
3
LIVN icon
LivaNova
LIVN
+$14M
4
FN icon
Fabrinet
FN
+$13.9M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
ACDC icon
ProFrac Holding
ACDC
+$26.1M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$21.4M
3
CUBI icon
Customers Bancorp
CUBI
+$16M
4
MTSI icon
MACOM Technology Solutions
MTSI
+$14.6M
5
PRFT
Perficient Inc
PRFT
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.06%
2 Technology 16.79%
3 Industrials 15.69%
4 Consumer Discretionary 14.06%
5 Financials 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REPL icon
51
Replimune Group
REPL
$859M
$17M 0.82%
963,041
-223,000
-19% -$5.3M
INSM icon
52
Insmed
INSM
$23.5B
$16.9M 0.81%
990,782
-4,131
-0.4% -$80.3K
ONT
53
Onterris Inc
ONT
$756M
$16.8M 0.81%
472,240
-5,465
-1% -$247K
VC icon
54
Visteon
VC
$2.8B
$16.5M 0.79%
105,150
-1,722
-2% -$267K
MRCY icon
55
Mercury Systems
MRCY
$5.77B
$16.3M 0.78%
318,913
-3,051
-0.9% -$154K
PRFT
56
DELISTED
Perficient Inc
PRFT
$16M 0.77%
221,373
-180,318
-45% -$13.2M
HLI icon
57
Houlihan Lokey
HLI
$9.67B
$15.9M 0.76%
182,033
-2,253
-1% -$212K
DCGO icon
58
DocGo
DCGO
$64.3M
$15.7M 0.75%
1,813,568
-27,770
-2% -$245K
RPD icon
59
Rapid7
RPD
$815M
$15.6M 0.75%
340,852
-44,927
-12% -$1.91M
CHUY
60
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$15.3M 0.73%
427,048
-5,632
-1% -$192K
CCOI icon
61
Cogent Communications
CCOI
$549M
$15.3M 0.73%
240,186
-13,533
-5% -$870K
EE icon
62
Excelerate Energy
EE
$1.24B
$15.2M 0.73%
687,613
-9,825
-1% -$218K
COHR icon
63
Coherent
COHR
$54.3B
$15.1M 0.73%
397,321
+5,286
+1% +$215K
HRI icon
64
Herc Holdings
HRI
$4.99B
$15.1M 0.73%
132,734
-2,391
-2% -$330K
MNKD icon
65
MannKind Corp
MNKD
$1.25B
$14.9M 0.71%
3,635,209
-79,559
-2% -$384K
ANIP icon
66
ANI Pharmaceuticals
ANIP
$1.8B
$14.8M 0.71%
373,406
-69,830
-16% -$2.94M
AMRC icon
67
Ameresco
AMRC
$1.22B
$14.8M 0.71%
300,015
-4,709
-2% -$250K
HAE icon
68
Haemonetics
HAE
$3.54B
$14.4M 0.69%
174,479
-1,695
-1% -$137K
KRTX
69
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$14M 0.67%
77,170
-23,760
-24% -$4.54M
BW icon
70
Babcock & Wilcox
BW
$1.47B
$13.8M 0.66%
2,270,675
+416,303
+22% +$2.57M
AHCO icon
71
AdaptHealth
AHCO
$1.49B
$13.7M 0.66%
1,104,373
-22,758
-2% -$419K
EYE icon
72
National Vision
EYE
$1.66B
$13.7M 0.66%
725,818
-54,485
-7% -$1.77M
RXDX
73
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$13.6M 0.65%
126,436
-23,253
-16% -$2.68M
FN icon
74
Fabrinet
FN
$17.1B
$13.3M 0.64%
+111,870
New +$13.9M
CERT icon
75
Certara
CERT
$1.08B
$12.7M 0.61%
526,695
-14,743
-3% -$291K
1 2
3
4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, Emerald Advisers held 266 positions worth $2.09B, up 0.76% from $2.07B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $86M in Q1 2023, closing 56 positions and reducing 134 holdings. Its most notable exit was ProFrac Holding, an estimated $26.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Emerald Advisers opened a new position in LivaNova worth $12.1M.

  • Emerald Advisers's largest Q1 2023 buy was LivaNova: 277,388 shares worth $12.1M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $18.8M increase.
  • Emerald Advisers's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $21.4M.
  • Emerald Advisers fully exited ProFrac Holding in Q1 2023, selling an estimated $26.1M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.09B portfolio in Q1 2023.
  • Emerald Advisers opened 20 new positions and closed 56 in Q1 2023.
  • Emerald Advisers's portfolio value rose 0.76% quarter-over-quarter to $2.09B.

Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.